businesspress24.com - Healthcare & Medical: Pressemitteilungen - Kategorie - Seite 1
 

Healthcare & Medical

Category / Healthcare & Medical


Everest Medicines Announces the Acceptance and Priority Review of VELSIPITY(R) Manufacturing Localization Application by the Center for Drug Evaluation of Chinas NMPA, Driving Continued Commercial Momentum

Hong Kong: Hong Kong, Oct 2, 2026 - (ACN Newswire) - Everest Medicines recently announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted the a ...

ESC 2026 Research Underscores the Burden of PSVT, Everest Medicines CARDAMYST(R) Offers an Out-of-Hospital, Self-Administered Treatment Option

Hong Kong: HONG KONG, Sept 21, 2026 - (ACN Newswire) - Everest Medicines announced findings from a longitudinal study describing how paroxysmal supraventricular tachycardia (PSVT) affects patients’ daily lives ...

OMRON Healthcare Marks 40 Years of Ohasama Study for World Heart Day

KYOTO, Japan: Landmark research continues to advance home blood pressure monitoring and preventive cardiovascular care ...

CMS: Initial Prescriptions for Silevimig Injection, the Worlds First Bispecific Antibody Against Rabies, Issued in China

SHENZHEN: SHENZHEN, Sept 9, 2026 - (ACN Newswire) - On 9 September, China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS” or the “Group”) is pleased to announce that the initial prescriptions for ...

AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership with Macro HRD SG Pte. Ltd.

Singapore: AcroMeta to acquire a strategic stake in Macro-ATCLS Pte. Ltd., for the Ambient Temperature Cellular Logistics business. Option to acquire an exclusive licence to deploy the Ambient Temperature Cellu ...

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI: Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196.SH; 02196.HK) today announced an H share repurchase plan, under which the company intends to repurchase its H sh ...

CMS (867.HK/8A8.SG): Innovative Drug Lumirix(R) Approved in China for Additional Indication of Atopic Dermatitis (AD)

SHENZHEN, CHINA: SHENZHEN, CHINA - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutic ...

Everest Medicines Strengthens Its Cardiovascular Portfolio with CARDAMYST(R) Approved for the Conversion of Acute Symptomatic Episodes of PSVT to Sinus Rhythm in Adults in China

HONG KONG: HONG KONG, Sept 3, 2026 - (ACN Newswire) - Everest Medicines today announced that China’s National Medical Products Administration (NMPA) has approved CARDAMYST(R) (etripamil) for the conversion of ...

Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum

HONG KONG: HONG KONG, August 19, 2026 - (ACN Newswire) - Everest Medicines (HKG: 01952) announced its interim results for the six months ended June 30, 2026. Everest delivered strong growth and reached an import ...

Santen Joins Inaugural Global Summit for Eye Health as High-Impact Partner

Osaka, Japan: Osaka, Japan, Aug 5, 2026 - (JCN Newswire) - Santen Pharmaceutical Co., Ltd. today announced it will join the inaugural Global Summit for Eye Health as a High Impact Partner, marking another step in t ...

Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib

HONG KONG: HONG KONG, July 8, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced the closing of its previously announced exclusive licensing and collaboration agreement with Travere Therapeutics, ...

Siloam International Hospitals Receives Magnet with Distinction(TM), Highest Global Standard for Nursing Excellence

JAKARTA,: Southeast Asia's Only Hospital Network with Two Hospitals Receiving Distinction ...

Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China

HONG KONG: HONG KONG, Jun 26, 2026 - (ACN Newswire) - June 26, 2026, Everest Medicines today announced that China’s National Medical Products Administration (NMPA) accepted the Biologics License Application (B ...

Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Heruis budesonide enteric capsules, further enhancing patient access to the medication

HONG KONG: HONG KONG, Jun 24, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Her ...

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the Worlds First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN: SHENZHEN, June 22, 2026 - (ACN Newswire) - China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Inj ...

Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia

HONG KONG: HONG KONG, Jun 16, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK)announced that it has entered into an exclusive licensing agreement with Australia Dimerix Limited (“Dimerix”), for the d ...

iHerb Expands Consumer Benefits Across Asia with 618 Shopping Festival

IRVINE, CA: IRVINE, CA, June 7, 2026 - (ACN Newswire) - iHerb, a global e‑commerce platform specializing in health and wellness products, has officially launched its 2026 “618 Peak Shopping Festival.” As a ...

ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801 Renoprotective Potential in Oral Presentation

Glasgow / Hong Kong: GLASGOW / HONG KONG - Jun 5, 2026 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), an innovative biopharmaceutical company specializing in the development of multifunctional, multi-targeted t ...


Page 1 von 304:  1 2  3  4  5  6  7  8  9  10  .. » 304





 

Who is online

All members: 10 721
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 3 623


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.